These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC. Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088 [Abstract] [Full Text] [Related]
4. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Trop Gastroenterol; 2007 Nov 01; 28(1):19-23. PubMed ID: 17896605 [Abstract] [Full Text] [Related]
5. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. J Med Virol; 2009 Mar 01; 81(3):406-12. PubMed ID: 19152393 [Abstract] [Full Text] [Related]
6. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. J Med Virol; 2009 Mar 01; 81(3):441-5. PubMed ID: 19152397 [Abstract] [Full Text] [Related]
8. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. J Med Virol; 2007 Oct 01; 79(10):1464-71. PubMed ID: 17705185 [Abstract] [Full Text] [Related]
10. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ. Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 01; 21(3):189-91. PubMed ID: 23967739 [Abstract] [Full Text] [Related]
11. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators. J Med Virol; 2007 Jun 01; 79(6):694-700. PubMed ID: 17457912 [Abstract] [Full Text] [Related]
13. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E. HIV Med; 2010 Jan 01; 11(1):85-9. PubMed ID: 19659944 [Abstract] [Full Text] [Related]
15. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness. Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM. J Med Virol; 2011 Sep 01; 83(9):1537-43. PubMed ID: 21739443 [Abstract] [Full Text] [Related]
16. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil. Aires RS, Matos MA, Lopes CL, Teles SA, Kozlowski AG, Silva AM, Filho JA, Lago BV, Mello FC, Martins RM. J Clin Virol; 2012 Aug 01; 54(4):327-31. PubMed ID: 22608842 [Abstract] [Full Text] [Related]
20. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. Raffa G, Maimone S, Cargnel A, Santantonio T, Antonucci G, Massari M, Schiavini M, Caccamo G, Pollicino T, Raimondo G. AIDS; 2007 Oct 18; 21(16):2171-5. PubMed ID: 18090043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]